ChromaDex inks distribution agreement with Sinopharm Xingsha to accelerate cross border sales of Tru Niagen into Mainland China
By, Admin1 min read
Share
ChromaDex Corp., a global bioscience company, has signed distribution agreement with Sinopharm Xingsha to accelerate cross-border sales of Tru Niagen into mainland China. Tru Niagen features ChromaDex
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
